Guests: Herman Saftlas, Standard & Poor's investment officer, and Frank
DiLorenzo, S&P analyst
Explore the market for stocks of pharmaceutical and biotech companies with
two Standard & Poor's experts. Find out what names hold the most promise for
your portfolio, in another of the chats presented every Tuesday at the same
time by BusinessWeek Online and S&P.
Our guests are S&P investment officer Herman Saftlas. He has more than 30
years of experience tracking stocks for S&P -- and has been checking out the
pharmas for 15 years. He's a graduate of Queens College in New York City.
Analyst Frank DiLorenzo has been covering the exciting biotech area for two
years at S&P. Previously, he was a fixed-income analyst for MetLife. He holds
an MBA from Rutgers.
The moderator of this chat with Herman and Frank will be Jack Dierdorff
(JackBW), consulting editor of BusinessWeek Online and former managing editor
of the magazine. Get your questions ready!